Successful treatment of chronic thromboembolic pulmonary hypertension with inhaled nitric oxide after right ventricular thrombectomy

被引：0

作者：

Takaba K. ^{[1
,2
]}

Aota M. ^{[1
]}

Nonaka M. ^{[1
]}

Sugimoto A. ^{[1
]}

Konishi Y. ^{[1
]}

机构：

[1] Department of Cardiovascular Surgery, Japan. Red Cross Soc. Wakayama M. C., Wakayama

[2] Department of Cardiovascular Surgery, Japan. Red Cross Soc. Wakayama M. C., Wakayama 640-8558

来源：

The Japanese Journal of Thoracic and Cardiovascular Surgery | 2004年 / 52卷 / 5期

关键词：

Chronic thromboembolic hypertension; Inhaled nitric oxide; Pulmonary thromboembolism;

D O I：

10.1007/s11748-004-0120-1

中图分类号：

学科分类号：

摘要：

We report a case of a 42-year-old male with chronic thromboembolic pulmonary hypertension. His preoperative examination revealed severe hypoxemia (PaO2 48 mmHg, PaCO2 34 mmHg in room air), a mass in the right ventricle and severe pulmonary hypertension (pulmonary arterial pressure 70/33 mmHg). We successfully performed right ventricular thrombectomy to prevent further embolization from the right ventricular thrombus. Using inhaled low dose nitric oxide (NO) during perioperative period, weaning from cardiopulmonary bypass and ventilator were easily done. In this case, inhaled NO was successfully administered for the perioperative management of chronic pulmonary hypertension.

引用

页码：257 / 260

页数：3

共 10 条

[1]

Palmer R.M., Ferrige A.G., Moncada S.A., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, pp. 524-526, (1987)

[2]

Girard C., Lehot J.J., Pannetier J.C., Filley S., Ffench P., Estanove S., Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension, Anesthesiology, 77, pp. 880-883, (1992)

[3]

Kearon C., Ginsberg J.S., Hirsh J., The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism, Ann Intern Med, 129, pp. 1044-1049, (1998)

[4]

The European Cooperative Study on the clinical significance of right heart thrombi, Eur Heart J, 10, pp. 1046-1059, (1989)

[5]

Frostell C.G., Blomqvist H., Hedenstierna G., Lundberg J., Zapol W.M., Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation, Anesthesidology, 78, pp. 427-435, (1993)

[6]

Steinhorn R.H., Fineman J.R., The pathophisiology of pulmonary hypertension in congenital heart disease, Artif Organs, 23, pp. 970-975, (1999)

[7]

Wessel D.L., Adatia I., Giglia T.M., Thompson J.E., Kulik T.J., Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass, Circulation, 88, pp. 2128-2138, (1993)

[8]

Pinelli G., Mertes P.M., Carteaux J.P., Hubert T., Dopff C., Burtin P., Et al., Inhaled nitric oxide as an adjunct to pulmonary thromboendarterectomy, Ann Thorac Surg, 61, pp. 227-229, (1996)

[9]

Trummer G., Berchtold-Herz M., Martin J., Beyersdorf F., Succesful treatment of pulmonary hypertension with inhaled nitric oxide after pulmonary embolectomy, Ann Thorac Surg, 73, pp. 1299-1301, (2002)

[10]

Markhorst D.G., Leehoven T., Ulterwijk J.W., Meulenbelt J., Van Vught A.J., Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting, Intensive Care Med, 22, pp. 954-958, (1996)

← 1 →